Conference Menu
Overview Day 1Day 2Register PDF Download Posters Hotel & Travel Sponsor Press Pass Request Brochure
Corporate Support Sponsor:
Sponsoring Publications:
Media Partner:
Speakers:
GlaxoSmithKline • Wyeth Research Berry Consultants • FDA • Merck
CONFERENCE FEATURES
Click here to view the following webcast:
Adaptive Clinical Trials Webcast
Guest: Jerald S. Schindler, Dr. P.H., Vice President, Biostatistics and Research Decision Sciences, Late Stage Clinical Development Statistics, Merck Research Laboratories
Who Should Attend:If you want to learn how to implement adaptive trial designs at your company and have responsibility in any of the following areas, this is a must attend event for you!
Quote from 2007 Attendee “This conference opened my eyes to the momentum behind adaptive trial designs.” - Dr. Patricia R., Vice President Inflammation, Clinical Development, Celgene Corporation
Scope of conference – Adaptive trial designs are improving the efficiency of drug development by saving time and money to run clinical trials as well as providing more information to select the right dose(s) for phase III confirmatory trials. In addition, regulatory authorities have communicated their willingness to consider and discuss the use of adaptive designs in clinical trials. Despite this, there are several issues which are preventing the wide spread implementation of adaptive designs; 1) technology, 2) information, and 3) experience.
Format and content - Rather than a series of 30 minute presentations, this conference is quite different. It will provide 3 to 4 in depth case studies in which Clinical researchers paired with technology and/or statistical professionals who are currently engaged in the planning and implementation of adaptive trials will provide detailed case studies from start to finish. These case studies will review:
In addition, 1-hour problem-solving breakout sessions which will allow meeting participants to speak directly with experts in the field will be provided. Desired Outcome – Attendees will have information regarding the technology needed and issues that arise during the planning and implementation of adaptive clinical trials and how to solve them in the area of:
Scientific AdvisorsMichael Krams, M.D., Assistant Vice President, Adapative Trials, Clinical Development Wyeth
Judith A. Quinlan, Ph.D., Vice President, Adaptive Designs, Cytel
Jerald S. Schindler, Dr.P.H., Vice President, Biostatistics and Research Decision Sciences, Late Stage Clinical Development Statistics, Merck Research Laboratories